Intralesional Therapy for Patients with Cutaneous Malignancies
Don’t forget about intralesional therapy as a treatment option for cutaneous malignancies, including non-melanoma and melanoma skin cancers, says Dr. Vishal A. Patel, director of cutaneous oncology at the GW Cancer Center. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Patel, who shared in which patients intralesional therapy may be …
Don’t forget about intralesional therapy as a treatment option for cutaneous malignancies, including non-melanoma and melanoma skin cancers, says Dr. Vishal A. Patel, director of cutaneous oncology at the GW Cancer Center. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Patel, who shared in which patients intralesional therapy may be … Continue reading "Intralesional Therapy for Patients with Cutaneous Malignancies"
Basal cell carcinoma (BCC) is the most common human cancer. When curative surgery and radiotherapy are contraindicated, systemic agents targeting the hedgehog signaling pathway are invaluable options for this subset of adult patients with locally advanced BCC (laBCC). Vismodegib and sonidegib are oral options with similar efficacy and side effect profiles. With the absence of head-to-head comparis … 
Verywell Health and several other media outlets are covering the issue of melanoma overdiagnosis in light of a recent study, which estimated more than 80,000 melanomas were overdiagnosed in white Americans in 2018 alone. Is melanoma overdiagnosis among white Americans a significant issue? What are the driving factors of overdiagnosis? What can dermatologists do better when diagnosing melanoma? … 
One of the latest TikTok trends has dermatologists concerned about the risks of pulmonary damage and allergic reactions. The “Lazy Girl” makeup trend involves applying self-tanner overnight to contour the face, according to FOX News. However, dermatologist Dr. Fayne Frey finds this trend disturbing, and dermatologist Dr. Mariano Busso cautions that results can vary.
Skin, hair and nail tren … 
Current field-directed treatments of actinic keratosis (AK), a pre-malignant condition, are often limited by severe local reactions and/or complex treatment. Tirbanibulin, a novel potent anti-proliferative synthetic agent that inhibits tubulin polymerization and Src kinase signalling, offers a convenient, safe, and effective field treatment of actinic keratosis. We continue our surgical Therapeut … 